GLPwatch
GLP-1 receptor agonists, CKD, and eGFR trajectory.
Lancet Diabetes Endocrinol · 2018
Last updated 2026-09-22| Journal | Lancet Diabetes Endocrinol, 2018 |
|---|---|
| Citations | 8 |
| Relative citation ratio | 0.30 |
| NIH percentile | 19 |
| Molecules | — |
| Conditions studied | Chronic Kidney Disease |
Full record and abstract on PubMed 30266180 ↗